TNF and cancer: Previously described mechanisms of minocycline anti-cancer action involve reduction of STAT3 phosphorylation, prevention of NF-κB activation, repression of tumor necrosis factor (TNF)α expression or inhibition of matrix metalloproteinases [33,34,35].